ArticleSpringerPlus2016
Suppression of Magnaporthe oryzae and interaction between Bacillus subtilis and rice plants in the control of rice blast.
Article in SpringerPlus, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Genome analysis and exploration ofFrontiers in microbiology · 2026Article
- Roles of Phyllosphere Microbes in Rice Health and Productivity.Plants (Basel, Switzerland) · 2024Review
- Article
- Article
- Communication between Plants and Rhizosphere Microbiome: Exploring the Root Microbiome for Sustainable Agriculture.Microorganisms · 2023Review
- RNA-Seq Provides Insights into the Mechanisms UnderlyingJournal of fungi (Basel, Switzerland) · 2022Article
- Anti-Fungal Analysis ofInternational journal of molecular sciences · 2022Article
- Diversity and Function of Appressoria.Pathogens (Basel, Switzerland) · 2021Review
- Transcriptomic and Ultrastructural Analyses ofFrontiers in microbiology · 2021Article
- Endophytic microbes: biodiversity, plant growth-promoting mechanisms and potential applications for agricultural sustainability.Antonie van Leeuwenhoek · 2020Review
- Screening and Application ofThe plant pathology journal · 2020Article
- Article
- Comparative Transcriptome Profiling ofFrontiers in microbiology · 2019Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Magnaporthe oryzae, the causative pathogen of rice blast, has caused extensive losses to rice cultivation worldwide. Strains of the bacterium Bacillus subtilis have been used as biocontrol agents against rice blast. However, little has been reported about the interaction between B. subtilis and the rice plant and its mechanism of action. Here, the colonization process and induced disease resistance by B. subtilis SYX04 and SYX20 in rice plants was examined. Strains of B. subtilis labeled with green fluorescent protein reached population of more than 5 × 10(6) CFU/g after 20 days on mature rice leaves and were detected after 3 days on newly grown leaves. Results showed that SYX04 and SYX20 not only inhibited spore germination, germ tube length, and appressorial formation but also caused a series of alterations in the structures of hyphae and conidia. The cell walls and membrane structures of the fungus showed ultrastructural abnormalities, which became severely degraded as observed through scanning electron microscopy and transmission electron microscopy. The mixture of both B. subtilis and M. oryzae resulted in enhanced activity of peroxidase, and polyphenol oxidase while there was significantly more superoxide dismutase activity in plants that had been sprayed with B. subtilis alone. The present study suggests that colonized SYX04 and SYX20 strains protected rice plants and exhibited antifungal activity and induced systemic resistance, thus indicating their potential biological control agents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.